Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Assets: 2011-2025

Historic Return on Assets for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to -0.36%.

  • Abeona Therapeutics' Return on Assets rose 35.00% to -0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.36%, marking a year-over-year increase of 35.00%. This contributed to the annual value of -0.79% for FY2024, which is 5.00% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Return on Assets is -0.36%, which was up 22.86% from -0.47% recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Return on Assets high stood at -0.36% for Q1 2021, and its period low was -2.04% during Q3 2022.
  • Moreover, its 3-year median value for Return on Assets was -0.73% (2023), whereas its average is -0.71%.
  • In the last 5 years, Abeona Therapeutics' Return on Assets crashed by 154bps in 2022 and then skyrocketed by 125bps in 2023.
  • Over the past 5 years, Abeona Therapeutics' Return on Assets (Quarterly) stood at -0.94% in 2021, then declined by 6bps to -1.00% in 2022, then increased by 27bps to -0.73% in 2023, then fell by 10bps to -0.83% in 2024, then soared by 35bps to -0.36% in 2025.
  • Its Return on Assets stands at -0.36% for Q3 2025, versus -0.47% for Q2 2025 and -0.96% for Q1 2025.